Christopher v. Smithkline Beecham Corp.
The Court ruled that pharmaceutical sales representatives who visit doctors to persuade them to prescribe a company's drugs qualify as "outside salesmen" under federal wage law, meaning they are not entitled to overtime pay.
In reaching that result, the Court also refused to defer to the Labor Department's own interpretation of its regulations, because the agency had changed its position and was trying to impose large back-pay liability on an industry that had followed a different understanding for decades.
How it got here: A federal trial court granted summary judgment for the employer; the Ninth Circuit affirmed; the Court took the case to resolve a split with the Second Circuit.
The Case in Depth
What happened
Two pharmaceutical sales representatives worked for years calling on physicians to persuade them to prescribe their employer's prescription drugs. They were well paid, worked largely unsupervised, and were not required to track their hours, but they were never paid extra for working more than 40 hours a week. They sued, arguing they should have received overtime pay under federal wage law.
The question before the Court
Are pharmaceutical sales reps who get doctors to agree, informally, to prescribe a drug counted as "outside salesmen" who don't get overtime pay?
The Court's answer
No — the Court ruled that pharmaceutical sales representatives who persuade doctors to prescribe their employer's drugs do qualify as "outside salesmen," so they are not entitled to overtime pay under federal wage law. The Court reached this conclusion by first refusing to give the Labor Department's own interpretation of its regulations the strong deference it normally receives, because the agency had switched its position and was trying to impose large retroactive liability on an industry with no advance warning.
Instead, the Court interpreted the law itself, reading the term "sale" broadly enough to cover a doctor's nonbinding commitment to prescribe a drug, since that is the most a sales representative can obtain in the heavily regulated prescription-drug industry. Because these employees functioned in every practical way like traditional salesmen, the Court held they fell within the overtime exemption.
Curious how the Court got there? See the step-by-step legal reasoning →
Why it matters
The ruling meant tens of thousands of pharmaceutical sales representatives nationwide remained ineligible for overtime pay, cutting off a wave of pending lawsuits seeking back overtime wages. It also signaled that courts will not always defer to an agency's last-minute legal interpretation, especially when it would spring unexpected liability on an entire industry.
What changes now
This is a final merits decision resolving a circuit split between the Second and Ninth Circuits, so no further proceedings on this legal question were required. The judgment in favor of the pharmaceutical company stands, and similarly situated pharmaceutical sales representatives elsewhere lost their basis for overtime claims under this reading of the outside salesman exemption. The Labor Department could still attempt formal rulemaking to establish a different rule going forward.
What this does not decide
The Court did not adopt a general rule that an employee automatically qualifies as a salesman merely by doing 'the most' possible to promote a product; it limited its holding to industries, like pharmaceuticals, where law or regulation prevents selling products in the ordinary direct manner. It also left the exempt-administrative-employee argument unresolved.
Concurrences and dissents
Dissent — Justice Breyer
“But it is the pharmacist, not the detailer, who will have sold the drug.”The dissent's core objection that detailers themselves never complete a sale.
Justice Breyer argued that detailers never actually 'sell' anything themselves — it is the pharmacist who eventually sells the drug — and that a doctor's nonbinding commitment is not a firm commitment to buy. He viewed detailers as performing nonexempt promotional work that stimulates sales made by someone else, not their own sales, and would have held them entitled to overtime pay.
How the Court got there
The legal reasoning, step by step
- The Court first considered whether to defer to the Labor Department's current interpretation of its own regulations under Auer deference — ordinarily strong deference given to an agency's reading of its own ambiguous rules. It found that deference unwarranted here because the agency had switched positions and was using litigation to impose massive retroactive liability on an industry with no fair warning.
- Because Auer deference did not apply, the Court gave the agency's view only the weaker, persuasion-based deference described in Skidmore v. Swift, weighing the thoroughness and consistency of the agency's reasoning rather than automatically adopting its conclusion.
- Applying that weaker standard, the Court found the agency's newest theory — that a 'sale' requires an actual transfer of legal ownership — unpersuasive because it conflicted with the wage law's own definition of 'sale,' which expressly includes a 'consignment for sale' that involves no transfer of ownership at all.
- Having set the agency's interpretation aside, the Court turned to the text of the overtime law itself, which exempts anyone working 'in the capacity of' an outside salesman — language the Court read as calling for a practical, industry-specific look at what the job actually involves rather than a rigid, technical test.
- The Court concluded that the law's broad catchall term for a 'sale' covers any arrangement that functions, within a particular industry's own rules, like a completed sale of a product — and that obtaining a doctor's nonbinding commitment to prescribe a drug is the functional equivalent of a sale in the heavily regulated prescription-drug industry.
- Because the sales representatives functioned in every practical respect like traditional salesmen — hired for sales skill, working unsupervised in the field, and paid through sales-based incentives — the Court held they fit within the outside salesman exemption as the DOL's own regulations define it.
Doctrinal impact
Cases affected by this decision
Limits Auer v. Robbins (519 U. S. 452)
The Court declined to apply Auer's usual deference to an agency's reading of its own regulation here.